What does this research mean for the field?

Percutaneous transluminal coronary angioplasty (PTCA) effectively controls unstable angina refractory to pharmacological treatment, although it is associated with high rates of restenosis that frequently require repeat procedures. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

January 1, 1992Japanese Circulation JournalOpen Access

Percutaneous Transluminal Coronary Angioplasty for Patients with Unstable Angina Pectoris.

View Full Paper

Ask AI

Bookmark

Why the study?

Does PTCA control symptoms in patients with unstable angina pectoris refractory to pharmacological treatment?

Population

76 patients with unstable angina pectoris refractory to pharmacological treatment

Design

Case_series

Authors

RHRyuichi HattoriKurume University YYY YuiKyoto University TATAKESHI AOYAMA

Discussion

Member takes

Implication

May relieve refractory unstable angina symptoms; leaves open durability and restenosis strategies in prospective trials.

Structured PICO

Does PTCA control symptoms in patients with unstable angina pectoris refractory to pharmacological treatment?

Population

76 patients with unstable angina pectoris refractory to pharmacological treatment

Intervention

Percutaneous transluminal coronary angioplasty (PTCA)

Outcome

Procedural success

PTCA can control refractory unstable angina but frequently requires repeat procedures due to high restenosis rates.

Cite This Study

Hattori et al. (1992) studied this question.

synapsesocial.com/papers/6a1beff01567d2fc4d5f49c8 https://doi.org/10.1253/jcj.56.1180

View Full Paper

Ask AI

Bookmark

Percutaneous Transluminal Coronary Angioplasty for Patients with Unstable Angina Pectoris.

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Percutaneous Transluminal Coronary Angioplasty for Patients with Unstable Angina Pectoris.

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider